Wave Life Sciences, Inc.
WVENasdaqCIK 1631574HealthcareFiscal year ends Dec 31
Reports and events: 260 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2707:50 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001193125-26-432714 |
| 2026-10-2707:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-432690 |
| 2026-10-1417:14 ET | DEF 14A | Proxy statementPeriod 2026-11-12 | 0001193125-26-421806 |
| 2026-08-1116:39 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000222 |
| 2026-07-3007:50 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-324949 |
| 2026-07-3007:38 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-324917 |
| 2026-06-2608:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-284002 |
| 2026-05-1816:51 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-229076 |
| 2026-05-0716:01 ET | DEF 14A | Proxy statementPeriod 2026-06-22 | 0001193125-26-211828 |
| 2026-04-3016:15 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001193125-26-197330 |
| 2026-04-2807:50 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-183587 |
| 2026-04-2807:34 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-183563 |
| 2026-04-2116:49 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-167070 |
| 2026-04-1716:57 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000110 |
| 2026-04-1516:08 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-157003 |
| 2026-03-3020:32 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000086 |
| 2026-03-2607:41 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-125092 |
| 2026-02-2607:50 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-073472 |
| 2026-02-2607:37 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-073437 |
| 2026-02-0207:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-032698 |
| 2026-01-1207:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009784 |
| 2025-12-1517:04 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-25-000072 |
| 2025-12-1121:47 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-314746 |
| 2025-12-0807:37 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-310595 |
| 2025-11-1707:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-283929 |
| 2025-11-1320:47 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-25-000055 |
| 2025-11-1007:46 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-273288 |
| 2025-11-1007:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-273278 |
| 2025-10-3006:04 ET | 8-K/A | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-257298 |
| 2025-10-2917:22 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-256682 |
| 2025-09-2408:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-214176 |
| 2025-09-0307:40 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-194511 |
| 2025-08-1117:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-178083 |
| 2025-08-0508:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-173053 |
| 2025-07-3007:45 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-099884 |
| 2025-07-3007:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-168644 |
| 2025-06-2316:31 ET | DEF 14A | Proxy statementPeriod 2025-08-05 | 0001193125-25-144678 |
| 2025-05-0807:45 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066404 |
| 2025-05-0807:36 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-115489 |
| 2025-04-2917:00 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0000950170-25-060301 |
| 2025-03-2607:38 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-063184 |
| 2025-03-0407:59 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-031322 |
| 2025-03-0407:51 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-044876 |
| 2025-01-1314:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005233 |
| 2024-11-2006:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-262067 |
| 2024-11-1207:40 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-124595 |
| 2024-11-1207:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-255157 |
| 2024-10-3017:13 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-247660 |
| 2024-10-1608:34 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-237869 |
| 2024-10-1517:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001193125-24-237665 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:33 ET. Listed shows no prices and gives no investment advice.